Παραπομπή σε μορφή APA (7η εκδ.)

Eaton, C., Wells, J., Holen, I., Croucher, P., & Hamdy, F. (2004). Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Παραπομπή σε μορφή Chicago (17η εκδ.)

Eaton, C., J. Wells, I. Holen, P. Croucher, και F. Hamdy. Serum Osteoprotegerin (OPG) Levels Are Associated with Disease Progression and Response to Androgen Ablation in Patients with Prostate Cancer. 2004.

Παραπομπή σε μορφή MLA (9th εκδ.)

Eaton, C., et al. Serum Osteoprotegerin (OPG) Levels Are Associated with Disease Progression and Response to Androgen Ablation in Patients with Prostate Cancer. 2004.